These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15636503)

  • 41. [Problems connected with the drug provision in the United States].
    Sloot HA
    Pharm Weekbl; 1969 Jul; 104(30):914-23. PubMed ID: 5800761
    [No Abstract]   [Full Text] [Related]  

  • 42. FDA user fee law poised for passage in Congress but not without stirring up controversy.
    Finkelstein J
    J Natl Cancer Inst; 2007 Jul; 99(14):1072-3. PubMed ID: 17623792
    [No Abstract]   [Full Text] [Related]  

  • 43. Sales of contaminated animal drugs halted.
    Henkel J
    FDA Consum; 1999; 33(5):34. PubMed ID: 10522171
    [No Abstract]   [Full Text] [Related]  

  • 44. Implementation of the Methamphetamine Anti-Proliferation Act; thresholds for retailers and for distributors required to submit mail order reports; changes to mail order reporting requirements. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Oct; 68(194):57799-804. PubMed ID: 14535265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Issues regarding the legal regulation of drugs in Argentina].
    Bignone IM
    Vertex; 2006; 17(67):220-3. PubMed ID: 16847481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Letter: FDA and the drug industry.
    Pitesky I
    Ann Allergy; 1974 Mar; 32(3):178. PubMed ID: 4405952
    [No Abstract]   [Full Text] [Related]  

  • 47. Drugs and the Washington climate.
    Durant TM
    Trans Am Clin Climatol Assoc; 1969; 80():196-204. PubMed ID: 4896316
    [No Abstract]   [Full Text] [Related]  

  • 48. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly.
    Vladeck DC
    Cornell Law Rev; 2008 Jul; 93(5):981-1002. PubMed ID: 18618967
    [No Abstract]   [Full Text] [Related]  

  • 50. Compounding problems and compounding confusion: federal regulation of compounded drug products and the FDAMA circuit split.
    Boodoo JM
    Am J Law Med; 2010; 36(1):220-47. PubMed ID: 20481406
    [No Abstract]   [Full Text] [Related]  

  • 51. Why are we Being Overcharged for Pharmaceuticals? What Should We Do About It?
    Hyman DA; Silver C
    J Leg Med; 2019; 39(2):137-149. PubMed ID: 31503533
    [No Abstract]   [Full Text] [Related]  

  • 52. Antibiotics, big business, and consumers. The context of government investigations into the postwar American drug industry.
    Bud R
    Technol Cult; 2005 Apr; 46(2):329-49. PubMed ID: 16116706
    [No Abstract]   [Full Text] [Related]  

  • 53. A gift to pharma?
    Nat Med; 2005 Jul; 11(7):693. PubMed ID: 16015340
    [No Abstract]   [Full Text] [Related]  

  • 54. Britain to combat conflicts of interest in drug regulators.
    Giles J
    Nature; 2004 Nov; 432(7015):263. PubMed ID: 15549064
    [No Abstract]   [Full Text] [Related]  

  • 55. Governmental influences on drug development: striking a better balance.
    Miller HI; Henderson DR
    Nat Rev Drug Discov; 2007 Jul; 6(7):532-9. PubMed ID: 17491596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The regulation of investigational drugs.
    Kessler DA
    N Engl J Med; 1989 Feb; 320(5):281-8. PubMed ID: 2643051
    [No Abstract]   [Full Text] [Related]  

  • 57. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL
    Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
    [No Abstract]   [Full Text] [Related]  

  • 58. Editorials: The FDA--reprise.
    Thomison JB
    J Tenn Med Assoc; 1973 Nov; 66(11):1071-2. PubMed ID: 4756263
    [No Abstract]   [Full Text] [Related]  

  • 59. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
    Tobbell DA
    Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bush tails follow-ons.
    Fox J
    Nat Biotechnol; 2008 Apr; 26(4):366. PubMed ID: 18392007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.